Daily phosphodiesterase type 5 inhibitor therapy: a new treatment option for prostatitis/prostatodynia?

The management of patients with chronic pelvic pain attributed to chronic prostatitis has always been rather unsatisfactory. Even prolonged treatment with an aminoquinolone, such as ciprofloxacin, and an anti‐inflammatory agent, or, alternatively an alpha‐blocker, seldom results in rapid resolution of the symptoms, and is commonly completely ineffective.
Source: Trends in Urology, Gynaecology and Sexual Health - Category: OBGYN Authors: Tags: Comment Source Type: research